ProKidney Corp.
PROK
$3.02
-$0.28-8.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.09% | 21.36% | -18.81% | -43.21% | -31.75% |
| Total Depreciation and Amortization | -8.44% | 1.65% | 5.92% | 17.01% | 15.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.28% | 29.29% | -75.50% | 35.77% | 4.46% |
| Change in Net Operating Assets | -269.90% | -93.66% | 6,626.02% | 96.42% | -29.47% |
| Cash from Operations | -6.16% | -22.43% | 17.34% | 23.64% | -10.53% |
| Capital Expenditure | -174.19% | 95.55% | -961.11% | -277.99% | 33.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -26.33% | -27.51% | 151.23% | -371.28% | -50.80% |
| Cash from Investing | -34.37% | 87.59% | 118.47% | -385.74% | -51.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -16.67% | 14.29% | 0.00% | -7.69% | 0.00% |
| Issuance of Common Stock | -- | -- | -96.94% | -96.80% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -16.67% | -109.76% | -97.24% | -96.81% | 1,075,807.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -878.33% | 85.34% | 91.57% | -181.79% | 448.10% |